New Real-World Data Show Pradaxa ® (dabigatran etexilate mesylate) Treatment Resulted in Less Use of All-Cause Healthcare Resources than Warfarin Treatment

Source: Boehringer Ingelheim Press Releases - Category: Research Source Type: news
More News: Research